Holoclara Inc

?? Holoclara has been selected as the winner of the Immunomodulatory Solution of the Year by the BioTech Breakthrough Awards! We’re proud to be developing first-in-class worm-derived therapies that could serve as breakthrough treatments for allergic and autoimmune disease. Read the full announcement ?? https://lnkd.in/gYXC6PQ5 #WormScience #WormsAsMedicine #Worms #WormTherapies #Allergies #Autoimmune #Biotech

A scientist and a reporter walk into a worm lab. If this is a story you haven’t heard before, check out Allie Garfinkle’s recent feature in Fortune interviewing our co-founders, CEO Andrea Choe and advisor Paul Sternberg, and one of our investors, Neal Bhadkamkar at BOLD Capital Partners. They discuss worm behavior, their long evolutionary history with humans, and how it all led to our development of breakthrough worm-derived therapies. Bonus: Learn why some worms are called “dumpys” or “uncs.” ?? https://lnkd.in/g-bQq4-g

The New York Times captures the incredible impact that #worms have made on science and medicine — including breakthroughs that have earned at least 4 Nobel Prizes. In honor of this year’s Nobel Prize in Chemistry, our team celebrates their ongoing contributions to biology as we harness worm-derived molecules to improve our health. For more on these “Worm Nobels,” read this delightful piece by Teddy Rosenbluth: https://lnkd.in/dKbmMFPs #WormScience #WormsAsMedicine #WormTherapies

What’s in a name? Our name Holoclara is derived from the Greek word ????????????ē?????? meaning “complete.” ????????????ē?????? reflects our mission to restore missing components of the human molecular legacy. To do so, we are harnessing worm-derived molecules into safe, orally available medicines.? Read more ?? holoclara.com #WormScience #WormsAsMedicine #Worms #WormTherapies #Allergies #Autoimmune #Biotech

Did you know that autoimmune and allergic diseases were rare before the 1900s? What changed? ???? Our co-founder and CEO Andrea Choe explores these questions on the latest episode of Life Sciences 360. Watch the full conversation with host Harsh Thakkar for more on how worms may be the key to tackling these diseases, and our work at Holoclara to develop worm-derived therapies. Watch the full episode: https://lnkd.in/gfBBKMHv #WormScience #WormsAsMedicine #Worms #WormTherapies #Allergies #Autoimmune #Biotech

Check out Forbes brand new science newsletter featuring our work harnessing worms for better human health! In the Prototype, Alex Knapp covers our co-founder and CEO Andrea Choe’s foundational discovery of worm-derived molecules that can suppress the inflammatory response in the immune system — and how our team is turning them into safe, orally available medicines that could benefit millions of patients. ??https://lnkd.in/gFGxvm_c #WormScience #WormsAsMedicine #Worms #WormTherapies #Allergies #Autoimmune #Biotech

Thrilled to see our co-founder and advisor Paul Sternberg honored with this new appointment at Caltech!

How could returning worm-derived molecules back into mankind improve our health? Such molecules have been proven to block inflammatory bowel disease, asthma, multiple sclerosis, and other disorders, explains our co-founder and CEO Andrea Choe at the recent Aspen Ideas: Health conference. Learn more by watching the rest of her conversation with CBS News Chief Medical Correspondent Jon LaPook: https://lnkd.in/grQMqaxk Aspen Ideas #AspenIdeasHealth #Worms #WormScience #WormTherapies #Allergies #Autoimmune #Biotech

We are pleased to announce Brian Varnum, Ph.D., as our Head of Research & Development. Read more below and on our website: https://www.holoclara.com Dr. Varnum brings more than 30 years of expertise in the biotechnology industry with recent roles as an executive and advisor for various organizations. At Holoclara, he will lead our R&D initiatives as we prepare to take our worm-derived therapeutics into clinical trials later this year. He is the former CEO and Chief Development Officer of Armata Pharmaceuticals, where he oversaw the growth and advancement of the company's pipeline of bacteriophage-based therapeutics; securing partnerships, funding, and regulatory approvals. Previously, Dr. Varnum served as Chief Development Officer of C3 Jian, Chief Scientific Officer of Tarrot, and Executive Director of Inflammation at Amgen. He received his Ph.D. in biochemistry and molecular biology from the University of California, Los Angeles (UCLA) and A.B. in biochemistry from the University of California, Berkeley.

On a new episode of the Progress, Potential, And Possibilities podcast, our co-founder and CEO Andrea Choe shares the benefits that reintroducing worms to mankind can bring to human health. Check out her interview with host Ira S. Pastor to learn more about our work transforming worm-derived molecules into therapeutics for allergic and autoimmune disease: https://lnkd.in/gHtWbyVX ?? #Worms #WormScience #WormTherapies #Allergies #Autoimmune #Biotech